Health Canada Reports On Public Feedback From Consultations On The Proposed Approach To Regulation Of Cannabis

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
The Government intends to publish final regulations as soon as possible following Royal Assent of the Cannabis Act.
Canada Food, Drugs, Healthcare, Life Sciences

Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts ("Cannabis Act") is currently before the Senate with a vote expected no later than June 7, 2018 (see Introduction of the Cannabis Act: Questions and Answers). The Government intends to publish final regulations as soon as possible following Royal Assent of the Cannabis Act. Rather than pre-publishing draft regulations, the Government released regulatory proposals by way of a consultation paper (previously reported). On March 19, 2018, Health Canada announced the release of its report entitled "Proposed Approach to the Regulation of Cannabis: Summary of Comments Received During the Public Consultation". The report provides a summary of comments received on the consultation paper, including on matters such as licences, permits and authorizations, security clearances, a national Cannabis Tracking System, cannabis products, packaging and labelling and cannabis for medical purposes, and also provides additional details on the proposed regulation in these and other areas.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More